Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Prostate Cancer

  Free Subscription

Articles published in BJU Int

Retrieve available abstracts of 132 articles:
HTML format

Single Articles

    October 2021
  1. MARRA G, Calleris G, Marquis A, Oderda M, et al
    Reply to letter by Montorsi et al. Re: Marra et al. 'Transperineal freehand multiparametric MRI fusion targeted biopsies under local anaesthesia for prostate cancer diagnosis: a multicentre prospective study of 1014 cases'.
    BJU Int. 2021;128:524.

  2. MONTORSI F, Stabile A, Gandaglia G, Fossati N, et al
    Re: Marra et al. 'Transperineal freehand multiparametric MRI fusion targeted biopsies under local anaesthesia for prostate cancer diagnosis: a multicentre prospective study of 1014 cases'.
    BJU Int. 2021;128:523.

  3. GULDBAEK MV, Fode M, Jensen CFS, Sonksen J, et al
    'Case of the Month' from Herlev and Gentofte Hospital, Denmark: metastatic prostate cancer in a man with late-onset hypogonadism following testosterone-replacement therapy.
    BJU Int. 2021;128:428-430.

  4. KELLY R, Anton A, Wong S, Shapiro J, et al
    Real-world use of first-generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration-resistant prostate cancer.
    BJU Int. 2021;128 Suppl 1:18-26.
    PubMed     Abstract available

    August 2021
  5. URIBE-LEWIS S, Uribe J, Bourke V, Deering C, et al
    Long-term survival after LDR Brachytherapy for Prostate Cancer: the Royal Surrey experience.
    BJU Int. 2021 Aug 27. doi: 10.1111/bju.15585.
    PubMed     Abstract available

  6. DOAN P, Graham P, Lahoud J, Remmers S, et al
    A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant?
    BJU Int. 2021 Aug 9. doi: 10.1111/bju.15554.
    PubMed     Abstract available

  7. ISRAEL B, Immerzeel J, van der Leest M, Hannink G, et al
    Clinical Implementation of Pre-biopsy MRI-Pathways for the Diagnosis of Prostate Cancer.
    BJU Int. 2021 Aug 6. doi: 10.1111/bju.15562.
    PubMed     Abstract available

  8. FDA approves a second PSMA targeting agent for PET imaging in men with prostate cancer.
    BJU Int. 2021;128:127-130.

    Multiparametric magnetic resonance imaging - a crucial imaging tool for considering and planning prostate cancer focal therapy.
    BJU Int. 2021;128:125-126.

  10. INOUE T, Sasaki T, Kato M, Masui S, et al
    Warning against second-generation antiandrogen for metastatic castration sensitive prostate cancer.
    BJU Int. 2021 Aug 1. doi: 10.1111/bju.15561.
    PubMed     Abstract available

    July 2021
  11. BUELENS S, Poelaert F, Claeys T, De Bleser E, et al
    Multicentric Prospective Local Treatment of Metastatic Prostate Cancer (LoMP) Study.
    BJU Int. 2021 Jul 21. doi: 10.1111/bju.15553.
    PubMed     Abstract available

  12. KAMRAN SC, Zietman AL
    Radiation Treatment in Prostate Cancer: Covering the Waterfront.
    BJU Int. 2021 Jul 17. doi: 10.1111/bju.15550.
    PubMed     Abstract available

  13. KREIS K, Horenkamp-Sonntag D, Schneider U, Zeidler J, et al
    Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer.
    BJU Int. 2021 Jul 9. doi: 10.1111/bju.15542.
    PubMed     Abstract available

  14. BENAFIF S, Ni Raghallaigh H, McGrowder E, Saunders EJ, et al
    The BARCODE1 Pilot: a feasibility study of using germline SNPs to target prostate cancer screening.
    BJU Int. 2021 Jul 2. doi: 10.1111/bju.15535.
    PubMed     Abstract available

    June 2021
  15. MORI K, Mostafaei H, Sari Motlagh R, Pradere B, et al
    Systemic Therapies for Metastatic Hormone-Sensitive Prostate Cancer: Network Meta-Analysis.
    BJU Int. 2021 Jun 25. doi: 10.1111/bju.15507.
    PubMed     Abstract available

  16. BERTONCELLI TANAKA M, Sahota K, Burn J, Falconer A, et al
    Prostate cancer in transgender women: what does a urologist need to know?
    BJU Int. 2021 Jun 22. doi: 10.1111/bju.15521.
    PubMed     Abstract available

    Prostate cancer: the interplay between genetics and the environment.
    BJU Int. 2021;127:615-616.

  18. YAXLEY J
    Letter to the Editor BJUI in response to Montorsi et al.: Histological comparison between predictive value of preoperative 3-T multiparametric MRI and (68) Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node di
    BJU Int. 2021;127:747.

  19. DIRIE J, Mahesan T, Hart E, Janardanan S, et al
    Delivering safe and timely cancer care during COVID-19: lessons and successes from the transition period.
    BJU Int. 2021;127:633-635.

  20. TANDOGDU Z, Collins J, Shaw G, Rohn J, et al
    Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statement.
    BJU Int. 2021;127:729-741.
    PubMed     Abstract available

  21. DINNEEN E, Haider A, Grierson J, Freeman A, et al
    NeuroSAFE frozen section during robot-assisted radical prostatectomy: peri-operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trial.
    BJU Int. 2021;127:676-686.
    PubMed     Abstract available

    May 2021
  22. EMMETT L, Subramaniam S, Joshua A, Crumbaker M, et al
    ENZA-p trial protocol: A randomised phase II trial using PSMA as a therapeutic target and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901).
    BJU Int. 2021 May 24. doi: 10.1111/bju.15491.
    PubMed     Abstract available

  23. MEIJER D, van Leeuwen PJ, Donswijk ML, Boellaard TN, et al
    Predicting Early Outcomes in Intermediate and High Risk Prostate Cancer Patients using PSMA PET and MRI.
    BJU Int. 2021 May 24. doi: 10.1111/bju.15492.
    PubMed     Abstract available

  24. KNIPPER S, Tilki D, Graefen M, Maurer T, et al
    Early prostate cancer recurrence with PSMA PET positive unilateral pelvic lesion(s): is one-sided salvage extended lymph node dissection enough? (ProSTone, NCT04271579).
    BJU Int. 2021 May 22. doi: 10.1111/bju.15485.
    PubMed     Abstract available

  25. O'CALLAGHAN M, Papa N, Pase M, Frydenberg M, et al
    Patterns of care for prostate cancer treatment and improving outcomes - are national registries the answer?
    BJU Int. 2021 May 11. doi: 10.1111/bju.15366.

  26. Recent advances in the diagnosis and management of prostate cancer.
    BJU Int. 2021;127:518-519.

  27. URKMEZ A, Ward JF, Choi H, Troncoso P, et al
    Temporal learning curve of a multidisciplinary team for magnetic resonance imaging/transrectal ultrasonography fusion prostate biopsy.
    BJU Int. 2021;127:524-527.

  28. INOUE S, Hayashi T, Teishima J, Matsubara A, et al
    Longitudinal evaluation of the frequency of sexual intercourse and sexual activity in patients after nerve-sparing robot-assisted laparoscopic radical prostatectomy.
    BJU Int. 2021;127:560-566.
    PubMed     Abstract available

  29. TUTOLO M, Bruyneel L, Van der Aa F, Van Damme N, et al
    A novel tool to predict functional outcomes after robot-assisted radical prostatectomy and the value of additional surgery for incontinence.
    BJU Int. 2021;127:575-584.
    PubMed     Abstract available

    April 2021
  30. CHILUKURI S, Murthy V
    Adjuvant radiation for prostate cancer: Too early to abandon?
    BJU Int. 2021 Apr 9. doi: 10.1111/bju.15422.
    PubMed     Abstract available

  31. LUNDGREN PO, Kjellman A, Norming U, Gustafsson O, et al
    Association Between One-time Prostate-Specific Antigen (PSA) Test with Free/Total PSA and Prostate Cancer Mortality: A 30-year Prospective Cohort Study.
    BJU Int. 2021 Apr 3. doi: 10.1111/bju.15417.
    PubMed     Abstract available

  32. XU AJ, Taylor J, Gao T, Mihalcea R, et al
    TikTok and Prostate Cancer: Misinformation and Quality of Information using Validated Questionnaires.
    BJU Int. 2021 Apr 2. doi: 10.1111/bju.15403.
    PubMed     Abstract available

  33. GALFANO A, Secco S, Dell'Oglio P, Rha K, et al
    Retzius-sparing robot-assisted radical prostatectomy: early learning curve experience in three continents.
    BJU Int. 2021;127:412-417.
    PubMed     Abstract available

    March 2021
  34. GNANAPRAGASAM V, Barrett T, Pacey S, Warren A, et al
    Does modern Active surveillance offer an opportunity for new therapeutic strategies in early prostate cancer?
    BJU Int. 2021 Mar 27. doi: 10.1111/bju.15409.
    PubMed     Abstract available

  35. MARSHALL CH, Tunacao J, Danda V, Tsai HL, et al
    Reversing the effects of androgen deprivation therapy in men with metastatic castration resistant prostate cancer.
    BJU Int. 2021 Mar 25. doi: 10.1111/bju.15408.
    PubMed     Abstract available

  36. ANING JJ, Parry MG, van der Meulen J, Fowler S, et al
    How reliable is surgeon reported data? : A comparison of the British Association of Urological Surgeons radical prostatectomy audit with the National Prostate Cancer Audit Hospital Episode Statistic linked database.
    BJU Int. 2021 Mar 22. doi: 10.1111/bju.15399.
    PubMed     Abstract available

  37. WESSELS F, Schmitt M, Krieghoff-Henning E, Jutzi T, et al
    Deep learning approach to predict lymph node metastasis directly from primary tumor histology in prostate cancer.
    BJU Int. 2021 Mar 11. doi: 10.1111/bju.15386.
    PubMed     Abstract available

  38. ROSENBERG JE, Jung JH, Edgerton Z, Lee H, et al
    Retzius-sparing versus standard robotic assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.
    BJU Int. 2021 Mar 9. doi: 10.1111/bju.15385.
    PubMed     Abstract available

  39. DHIANTRAVAN N, Emmett L, Joshua AM, Pattison DA, et al
    UpFrontPSMA: A Randomised Phase 2 Study of Sequential (177) Lu-PSMA617 and Docetaxel versus Docetaxel in Metastatic Hormone-Naive Prostate Cancer.
    BJU Int. 2021 Mar 7. doi: 10.1111/bju.15384.
    PubMed     Abstract available

  40. The FDA Approves PSMAtargeted Drug for PET Imaging in Men with Prostate Cancer.
    BJU Int. 2021;127:267-268.

  41. BARRETT T, Padhani AR, Patel A, Ahmed HU, et al
    Certification in reporting multiparametric magnetic resonance imaging of the prostate: recommendations of a UK consensus meeting.
    BJU Int. 2021;127:304-306.

  42. NYBERG M, Sjoberg DD, Carlsson SV, Wilderang U, et al
    Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial.
    BJU Int. 2021;127:361-368.
    PubMed     Abstract available

    February 2021
  43. SOETERIK TFW, Hueting TA, Israel B, van Melick HHE, et al
    External validation of the MSKCC and Briganti Nomograms For Prediction of Lymph Node Involvement of Prostate Cancer Using Clinical Stage assessed by Magnetic Resonance Imaging.
    BJU Int. 2021 Feb 25. doi: 10.1111/bju.15376.
    PubMed     Abstract available

  44. DUNN J, Heathcote P, Chambers SK
    Prostate Cancer Survivorship Care: If not now, when?
    BJU Int. 2021 Feb 10. doi: 10.1111/bju.15358.
    PubMed     Abstract available

  45. ASLIM EJ, Law YXT, Fook-Chong SMC, Ho HSS, et al
    Defining prostate cancer size and treatment margin for focal therapy: does intra-lesional heterogeneity impact the performance of multiparametric MRI?
    BJU Int. 2021 Feb 4. doi: 10.1111/bju.15355.
    PubMed     Abstract available

  46. O'CONNOR LP, Lebastchi AH, Fasaye GA, Dikoglu E, et al
    'Case of the Month' from the National Cancer Institute, Bethesda, MD, USA: investigating genetic aberrations in a patient with high-risk prostate cancer.
    BJU Int. 2021;127:171-174.

  47. HUANG MM, Su ZT, Becker REN, Pavlovich CP, et al
    Complications after open and robot-assisted radical prostatectomy and association with postoperative opioid use: an analysis of data from the PREVENTER trial.
    BJU Int. 2021;127:190-197.
    PubMed     Abstract available

    January 2021
  48. ANDREWS JR, Hebert KJ, Boswell TC, Avant RA, et al
    Pubectomy and Urinary Reconstruction Provides Definitive Treatment of Urosymphyseal Fistula Following Prostate Cancer Treatment.
    BJU Int. 2021 Jan 5. doi: 10.1111/bju.15333.
    PubMed     Abstract available

  49. AHO T, Al-Hayek S, Winterbottom A, Koo B, et al
    'Case of the Month' from Cambridge University, UK: managing intractable bleeding from a 375 cc prostate in an anti-coagulated patient.
    BJU Int. 2021;127:37-40.

  50. World News.
    BJU Int. 2021;127:1-3.

  51. COVAS MOSCHOVAS M, Bhat S, Onol F, Rogers T, et al
    Early outcomes of single-port robot-assisted radical prostatectomy: lessons learned from the learning-curve experience.
    BJU Int. 2021;127:114-121.
    PubMed     Abstract available

    December 2020
  52. LONERGAN PE, Vertosick EA, Assel M, Sjoberg DD, et al
    Prospective validation of microseminoprotein-beta added to the 4Kscore in predicting high-grade prostate cancer in an international multi-center cohort.
    BJU Int. 2020 Dec 11. doi: 10.1111/bju.15320.
    PubMed     Abstract available

  53. MURPHY C, de Laine C, Macaulay M, Fader M, et al
    A multicentre exploratory study of the impact of urinary incontinence in the 6 weeks after catheter removal following radical prostatectomy.
    BJU Int. 2020;126:667-669.

  54. SUH J, Yoo S, Park J, Cho SY, et al
    Development and validation of an explainable artificial intelligence-based decision-supporting tool for prostate biopsy.
    BJU Int. 2020;126:694-703.
    PubMed     Abstract available

    November 2020
  55. MONTORSI F, Gandaglia G, Fossati N, Deho F, et al
    Re: Histological comparison between predictive value of preoperative 3-T multiparametric MRI and 68Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.
    BJU Int. 2020 Nov 29. doi: 10.1111/bju.15308.
    PubMed     Abstract available

  56. EGEVAD L, Delahunt B, Bostwick DG, Cheng L, et al
    Prostate Cancer Grading, Time To Go Back To the Future.
    BJU Int. 2020 Nov 18. doi: 10.1111/bju.15298.
    PubMed     Abstract available

  57. NORRIS JM, Carmona Echeverria LM, Simpson BS, Ball R, et al
    Conspicuity of cribriform prostate cancer on multiparametric magnetic resonance imaging: the jury is still out.
    BJU Int. 2020 Nov 13. doi: 10.1111/bju.15295.
    PubMed     Abstract available

  58. POULSON M, Helrich S, Kenzik K, Dechert T, et al
    The Impact of Residential Segregation on Prostate Cancer Diagnosis and Treatment.
    BJU Int. 2020 Nov 9. doi: 10.1111/bju.15293.
    PubMed     Abstract available

  59. QIU X, Li Y, Chen M, Xu L, et al
    Retzius-sparing robot-assisted radical prostatectomy improves early recovery of urinary continence: a randomized, controlled, single-blind trial with a 1-year follow-up.
    BJU Int. 2020;126:633-640.
    PubMed     Abstract available

  60. FENG T, Heulitt G, Lee JJ, Liao M, et al
    Randomised comparison of techniques for control of the dorsal venous complex during robot-assisted laparoscopic radical prostatectomy.
    BJU Int. 2020;126:586-594.
    PubMed     Abstract available

  61. EDISON MA, Connor MJ, Miah S, El-Husseiny T, et al
    Understanding virtual urology clinics: a systematic review.
    BJU Int. 2020;126:536-546.
    PubMed     Abstract available

  62. LEE AYM, Yang XY, Lee HJ, Law YM, et al
    Multiparametric MRI-ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic-assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy.
    BJU Int. 2020;126:568-576.
    PubMed     Abstract available

    October 2020
  63. SCHOOTS IG, Padhani AR
    Risk-adapted biopsy decision based on prostate MRI and PSA-density for enhanced biopsy avoidance in first prostate cancer diagnostic work-up.
    BJU Int. 2020 Oct 21. doi: 10.1111/bju.15277.
    PubMed     Abstract available

  64. FUJIHARA A, Iwata T, Shakir A, Tafuri A, et al
    Multiparametric Magnetic Resonance Imaging Facilitates Reclassification During Active Surveillance for Prostate Cancer.
    BJU Int. 2020 Oct 11. doi: 10.1111/bju.15272.
    PubMed     Abstract available

  65. EXTERKATE L, Peters M, Somford DM, Vergunst H, et al
    Functional and oncological outcomes of salvage cryosurgery for radiorecurrent prostate cancer.
    BJU Int. 2020 Oct 11. doi: 10.1111/bju.15269.
    PubMed     Abstract available

  66. NAIR SM, Hatiboglu G, Relle J, Hetou K, et al
    MRI-Guided Transurethral Ultrasound Ablation in Patients with Localized Prostate Cancer: Three Year Outcomes of a Prospective Phase I Study.
    BJU Int. 2020 Oct 9. doi: 10.1111/bju.15268.
    PubMed     Abstract available

  67. WHISH-WILSON T, Costello D, Finch S, Sutherland T, et al
    Funding of prostate magnetic resonance imaging leads to fewer biopsies and potential savings to health systems in the management of prostate cancer.
    BJU Int. 2020 Oct 6. doi: 10.1111/bju.15231.
    PubMed     Abstract available

    September 2020
  68. STROMAN L, Cathcart P, Lamb A, Challacombe B, et al
    A cross-section of UK prostate cancer diagnostics during the COVID-19 era - a shifting paradigm?
    BJU Int. 2020 Sep 27. doi: 10.1111/bju.15259.
    PubMed     Abstract available

  69. DIAO W, Cao Y, Su D, Jia Z, et al
    (68) Ga-prostate-specific membrane antigen tracers can alter the management of more than half of prostate cancer patients with biochemical recurrence.
    BJU Int. 2020 Sep 26. doi: 10.1111/bju.15257.
    PubMed     Abstract available

  70. MADAN RA, Karzai FH, Al Harthy M, Petrylak DP, et al
    Cabozantinib plus Docetaxel and Prednisone in Metastatic Castrate Resistant Prostate Cancer.
    BJU Int. 2020 Sep 24. doi: 10.1111/bju.15227.
    PubMed     Abstract available

  71. MARVASO G, Montesano M, Corrao G, De Angelis SP, et al
    Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom?
    BJU Int. 2020 Sep 24. doi: 10.1111/bju.15228.
    PubMed     Abstract available

  72. GOLDBERG H, Glicksman R, Woon D, Hoffman A, et al
    Can postreatment free psa ratio be used to predict adverse outcomes in recurrent prostate cancer?
    BJU Int. 2020 Sep 14. doi: 10.1111/bju.15236.
    PubMed     Abstract available

  73. ODERDA M, Diamand R, Albisinni S, Calleris G, et al
    Indications and complications of pelvic lymph node dissection for prostate cancer: are currently available nomograms accurate to predict lymph node invasion?
    BJU Int. 2020 Sep 1. doi: 10.1111/bju.15220.
    PubMed     Abstract available

  74. CAHILL D
    How the Martini-Klinik handled prostate surgery during COVID-19.
    BJU Int. 2020;126:E1.

  75. COWAN T, Baker E, McCray G, Reeves F, et al
    Detection of clinically significant cancer in the anterior prostate by transperineal biopsy.
    BJU Int. 2020;126 Suppl 1:33-37.
    PubMed     Abstract available

  76. FRANKLIN A, Gianduzzo T, Yaxley J, Kua B, et al
    Use of a trizonal schema to assess targeting accuracy in prostatic fusion biopsy.
    BJU Int. 2020;126 Suppl 1:6-11.
    PubMed     Abstract available

  77. ROCCO B, Sighinolfi MC, Cimadamore A, Reggiani Bonetti L, et al
    Digital frozen section of the prostate surface during radical prostatectomy: a novel approach to evaluate surgical margins.
    BJU Int. 2020;126:336-338.

    August 2020
  78. VEERMAN H, van Leeuwen PJ, Bekers E, van der Poel HG, et al
    Case of the month from the Netherlands Cancer Institute, Amsterdam: how to differentiate between benign and malignant prostatic cysts.
    BJU Int. 2020;126:240-244.

  79. ZHOU X, Fu B, Zhang C, Liu W, et al
    Transvesical robot-assisted radical prostatectomy: initial experience and surgical outcomes.
    BJU Int. 2020;126:300-308.
    PubMed     Abstract available

  80. NEALE A, Stroman L, Kum F, Jabarkhyl D, et al
    Targeted and systematic cognitive freehand-guided transperineal biopsy: is there still a role for systematic biopsy?
    BJU Int. 2020;126:280-285.
    PubMed     Abstract available

    July 2020
    Prostate cancer screening and treatment: where have we come from and where are we going?
    BJU Int. 2020 Jul 27. doi: 10.1111/bju.15153.
    PubMed     Abstract available

  82. UCHIMOTO T, Komura K, Fukuokaya W, Kimura T, et al
    Risk Stratification for the Prediction of Overall Survival Could Assists Treatment Decision Making at the Diagnosis of Castration-Resistant Prostate Cancer - a Multicenter Collaborative Study in Japan.
    BJU Int. 2020 Jul 23. doi: 10.1111/bju.15187.
    PubMed     Abstract available

  83. DUNN J, Green A, Ralph N, Newton RU, et al
    Prostate Cancer Survivorship Essentials Framework: Guidelines for Practitioners.
    BJU Int. 2020 Jul 5. doi: 10.1111/bju.15159.
    PubMed     Abstract available

  84. CHECCUCCI E, De Cillis S, Pecoraro A, Peretti D, et al
    Single-port robot-assisted radical prostatectomy: a systematic review and pooled analysis of the preliminary experiences.
    BJU Int. 2020;126:55-64.
    PubMed     Abstract available

  85. TAMHANKAR AS, El-Taji O, Vasdev N, Foley C, et al
    The clinical and financial implications of a decade of prostate biopsies in the NHS: analysis of Hospital Episode Statistics data 2008-2019.
    BJU Int. 2020;126:133-141.
    PubMed     Abstract available

  86. BERRY B, Parry MG, Sujenthiran A, Nossiter J, et al
    Comparison of complications after transrectal and transperineal prostate biopsy: a national population-based study.
    BJU Int. 2020;126:97-103.
    PubMed     Abstract available

    June 2020
  87. MATTI B, Lyndon M, Zargar-Shoshtari K
    Ethnic and Socioeconomic disparities in Prostate Cancer Screening - Lessons from New Zealand.
    BJU Int. 2020 Jun 29. doi: 10.1111/bju.15155.
    PubMed     Abstract available

  88. CHEN MY, Franklin A, Yaxley J, Gianduzzo T, et al
    Solitary rib lesions showing PSMA uptake in pre-treatment staging (68) Ga-PSMA-11 PET scans for men with prostate cancer: benign or malignant?
    BJU Int. 2020 Jun 27. doi: 10.1111/bju.15152.
    PubMed     Abstract available

  89. ANTON A, Kamel Hasan O, Ballok Z, Bowden P, et al
    Use of PSMA PET/CT in Response Assessment Following Upfront Chemohormonal Therapy in Metastatic Prostate Cancer.
    BJU Int. 2020 Jun 24. doi: 10.1111/bju.15151.
    PubMed     Abstract available

  90. MAYOR N, Sathianathen NJ, Buteau J, Koschel S, et al
    PSMA Theranostics in advanced prostate cancer: an evolving option.
    BJU Int. 2020 Jun 19. doi: 10.1111/bju.15143.
    PubMed     Abstract available

  91. TOMER A, Nieboer D, Roobol MJ, Bjartell A, et al
    Personalized Biopsy Schedules Based on Risk of Gleason Upgrading for Low-Risk Prostate Cancer Active Surveillance Patients.
    BJU Int. 2020 Jun 12. doi: 10.1111/bju.15136.
    PubMed     Abstract available

  92. PFISTER D, Haidl F, Nestler T, Verburg F, et al
    (68) Ga-PSMA-PET/CT helps to select patients for salvage radical prostatectomy with local recurrence after primary radiotherapy for prostate cancer.
    BJU Int. 2020 Jun 12. doi: 10.1111/bju.15135.
    PubMed     Abstract available

  93. FRANKLIN A, Yaxley WJ, Raveenthiran S, Coughlin G, et al
    Histological comparison between predictive value of pre-operative 3T multiparametric MRI and (68) Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.
    BJU Int. 2020 Jun 10. doi: 10.1111/bju.15134.
    PubMed     Abstract available

  94. AKAKURA K, Bolton D, Grillo V, Mermod N, et al
    Not All Prostate Cancer is the Same - Patient perceptions: An Asia-Pacific study.
    BJU Int. 2020 Jun 10. doi: 10.1111/bju.15129.
    PubMed     Abstract available

    Low-dose-rate brachytherapy for prostate cancer stands the test of time - the Swiss experience.
    BJU Int. 2020;125:750-751.

  96. SEETHARAM BHAT KR, Moschovas MC, Onol FF, Sandri M, et al
    Trends in clinical and oncological outcomes of robot-assisted radical prostatectomy before and after the 2012 US Preventive Services Task Force recommendation against PSA screening: a decade of experience.
    BJU Int. 2020;125:884-892.
    PubMed     Abstract available

    May 2020
  97. MARRA G, Zhuang J, Beltrami M, Calleris G, et al
    Transperineal free-hand mpMRI fusion targeted biopsies under local anesthesia for Prostate Cancer Diagnosis: a multicenter prospective study of 1,014 cases.
    BJU Int. 2020 May 26. doi: 10.1111/bju.15121.
    PubMed     Abstract available

  98. POPERT R, Kum F, MacAskill F, Stroman L, et al
    Our First Month of Delivering the Prostate Cancer Diagnostic Pathway within the Limitations of COVID-19 Using Local Anaesthetic Transperineal Biopsy.
    BJU Int. 2020 May 26. doi: 10.1111/bju.15120.
    PubMed     Abstract available

  99. WURNSCHIMMEL C, Maurer T, Knipper S, von Breunig F, et al
    Martini-Klinik experience on prostate cancer surgery during the early phase of COVID-19.
    BJU Int. 2020 May 18. doi: 10.1111/bju.15115.
    PubMed     Abstract available

  100. JOSHI A, Roberts MJ, Alinezhad S, Williams ED, et al
    Challenges, applications and future directions of precision medicine in prostate cancer - the role of organoids and patient-derived xenografts.
    BJU Int. 2020 May 8. doi: 10.1111/bju.15103.
    PubMed     Abstract available

  101. SCHWEN ZR, Mamawala M, Tosoian JJ, Druskin SC, et al
    Prostate Health Index and Multiparametric MRI to Predict Prostate Cancer Grade Reclassification in Active Surveillance.
    BJU Int. 2020 May 4. doi: 10.1111/bju.15101.
    PubMed     Abstract available

  102. SHAPIRO DD, Ward JF, Lim AH, Nogueras-Gonzalez GM, et al
    Comparing confirmatory biopsy outcomes between MRI-targeted biopsy and standard systematic biopsy among men being enrolled in prostate cancer active surveillance.
    BJU Int. 2020 May 1. doi: 10.1111/bju.15100.
    PubMed     Abstract available

  103. HAEUSER L, Nguyen DD, Trinh QD
    Prostate cancer and kidney transplantation - exclusion or co-existence?
    BJU Int. 2020;125:628-629.

  104. NABI J
    The provision of comfort: addressing barriers to sleep in prostate cancer.
    BJU Int. 2020;125:627-628.

  105. SIGHINOLFI MC, Eissa A, Spandri V, Puliatti S, et al
    Positive surgical margin during radical prostatectomy: overview of sampling methods for frozen sections and techniques for the secondary resection of the neurovascular bundles.
    BJU Int. 2020;125:656-663.
    PubMed     Abstract available

  106. YAMAMOTO A, Kato M, Hattori K, Naito Y, et al
    Propensity score-matched comparison of docetaxel and androgen receptor axis-targeted agents in patients with castration-resistant intraductal carcinoma of the prostate.
    BJU Int. 2020;125:702-708.
    PubMed     Abstract available

    April 2020
  107. SEYMOUR ZA, Hamstra DA, Daignault-Newton S, Bosch W, et al
    Long-term Follow-up After Radiotherapy for Prostate Cancer with and without Rectal Hydrogel Spacer: A Pooled Prospective Evaluation of Bowel Associated Quality of Life.
    BJU Int. 2020 Apr 25. doi: 10.1111/bju.15097.
    PubMed     Abstract available

  108. HEIDENREICH A, Bludau M, Bruns C, Nestler T, et al
    Pelvic exenteration surgery in patients with locally advanced castration-naive and castration-resistant, symptomatic prostate cancer.
    BJU Int. 2020 Apr 22. doi: 10.1111/bju.15088.
    PubMed     Abstract available

  109. NORRIS JM, Carmona Echeverria LM, Simpson BS, Allen C, et al
    Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: High Gleason Grade and Increased Tumour Volume are Not the Only Important Histopathological Features.
    BJU Int. 2020 Apr 22. doi: 10.1111/bju.15085.
    PubMed     Abstract available

  110. MANNAERTS CK, Engelbrecht MRW, Postema AW, van Kollenburg RAA, et al
    Detection of clinically significant prostate cancer in biopsy-naive men: Head-to-head comparison of systematic biopsy, multiparametric MRI- and contrast ultrasound dispersion imaging-targeted biopsy.
    BJU Int. 2020 Apr 21. doi: 10.1111/bju.15093.
    PubMed     Abstract available

  111. SZARVAS T, Csizmarik A, Fazekas T, Huttl A, et al
    Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer.
    BJU Int. 2020 Apr 20. doi: 10.1111/bju.15086.
    PubMed     Abstract available

  112. BORNO HT, Zhang S, Bakke B, Bell A, et al
    Disparities and Online Health Information: YouTube and Prostate Cancer Clinical Trials.
    BJU Int. 2020 Apr 10. doi: 10.1111/bju.15081.
    PubMed     Abstract available

  113. ORRASON AW, Westerberg M, Garmo H, Franck Lissbrant I, et al
    Changes in treatment and mortality in men with locally advanced prostate cancer between 2000-2016. Nationwide, population-based study in Sweden.
    BJU Int. 2020 Apr 10. doi: 10.1111/bju.15077.
    PubMed     Abstract available

    Estimating the threat posed by prostate cancer.
    BJU Int. 2020;125:480-481.

  115. STONIER T, Cathcart P
    Further evidence that surgery after focal therapy for prostate cancer is safe.
    BJU Int. 2020;125:481-482.

  116. TUGCU V, Eksi M, Sahin S, Colakoglu Y, et al
    Robot-assisted radical perineal prostatectomy: a review of 95 cases.
    BJU Int. 2020;125:573-578.
    PubMed     Abstract available

  117. ROCCO B, Sighinolfi MC, Bertoni L, Spandri V, et al
    Real-time assessment of surgical margins during radical prostatectomy: a novel approach that uses fluorescence confocal microscopy for the evaluation of peri-prostatic soft tissue.
    BJU Int. 2020;125:487-489.

  118. BRYANT RJ, Oxley J, Young GJ, Lane JA, et al
    The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression.
    BJU Int. 2020;125:506-514.
    PubMed     Abstract available

  119. HERRERA-CACERES JO, Nason GJ, Salgado-Sanmamed N, Goldberg H, et al
    Salvage radical prostatectomy following focal therapy: functional and oncological outcomes.
    BJU Int. 2020;125:525-530.
    PubMed     Abstract available

  120. WAJSWOL E, Winoker JS, Anastos H, Falagario U, et al
    A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion-guided biopsy: assessing the impact of inter-reader variability on cancer detection.
    BJU Int. 2020;125:531-540.
    PubMed     Abstract available

    March 2020
  121. OSSES DF, Drost FH, Verbeek JFM, Luiting HB, et al
    Prostate cancer upgrading with serial prostate MRI scans and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
    BJU Int. 2020 Mar 31. doi: 10.1111/bju.15065.
    PubMed     Abstract available

  122. AHLERING TE, Huynh LM, Towe M, See K, et al
    Testosterone replacement therapy reduces biochemical recurrence post-radical prostatectomy.
    BJU Int. 2020 Mar 2. doi: 10.1111/bju.15042.
    PubMed     Abstract available

  123. TEOH JY, Chiong E, Ng CF
    Can artificial intelligence optimize case selection for hemi-gland ablation?
    BJU Int. 2020;125:333-334.

  124. GLASER ZA, Rais-Bahrami S
    Magnetic resonance imaging as a personalised tool to safely avoid prostate biopsy.
    BJU Int. 2020;125:335-336.

  125. FRANCOLINI G, Jereczek-Fossa BA, Di Cataldo V, Simontacchi G, et al
    Stereotactic radiotherapy for prostate bed recurrence after prostatectomy, a multicentric series.
    BJU Int. 2020;125:417-425.
    PubMed     Abstract available

    February 2020
  126. ALLOTT EH, Csizmadi I, Howard LE, Muller RL, et al
    Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.
    BJU Int. 2020;125:226-233.
    PubMed     Abstract available

  127. HANSEN NL, Barrett T, Lloyd T, Warren A, et al
    Optimising the number of cores for magnetic resonance imaging-guided targeted and systematic transperineal prostate biopsy.
    BJU Int. 2020;125:260-269.
    PubMed     Abstract available

  128. SAAD M, Moschini M, Stabile A, Macek P, et al
    Long-term functional and oncological outcomes of nerve-sparing and prostate capsule-sparing cystectomy: a single-centre experience.
    BJU Int. 2020;125:253-259.
    PubMed     Abstract available

  129. KUM F, Elhage O, Maliyil J, Wong K, et al
    Initial outcomes of local anaesthetic freehand transperineal prostate biopsies in the outpatient setting.
    BJU Int. 2020;125:244-252.
    PubMed     Abstract available

    January 2020
  130. ONOL FF, Bhat S, Moschovas M, Rogers T, et al
    Comparison of outcomes of salvage robot-assisted laparoscopic prostatectomy for post-primary radiation vs focal therapy.
    BJU Int. 2020;125:103-111.
    PubMed     Abstract available

  131. KHAN-RUF S, Thurairajah R, Khan MS, Bultitude M, et al
    Digging through a genomic goldmine: defining the optimum upper urinary tract surveillance strategy for Lynch syndrome.
    BJU Int. 2020;125:6-7.

    August 2019
  132. SALTER CA, Mulhall JP
    Guideline of Guidelines: Testosterone Replacement Therapy for Testosterone Deficiency.
    BJU Int. 2019 Aug 17. doi: 10.1111/bju.14899.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.